NanoView Diagnostics
Latest round
- Series B
Last raised
- Oct 2018
Total raised
- $10M
Investors
- 3
About NanoView Diagnostics
NanoView Diagnostics Inc.NanoView Diagnostics Inc. was founded in 2015 and is headquartered in Boston, US. The company specializes in advanced diagnostics, particularly for gene therapy applications. In May 2022, NanoView was acquired by Unchained Labs, which will allow it to enhance its product offerings by integrating technologies like LentiView for gene therapy researchers. George Daaboul is the founder of the company, while Jerry Williamson serves as the CEO.NanoView Diagnostics Inc. provides advanced diagnostic tools aimed at the analysis and characterization of biological samples, specifically for gene therapy. Their flagship product, LentiView, analyzes lentivirus samples, facilitating the determination of critical parameters.NanoView operates on a business-to-business (B2B) revenue model, generating income through the sales of its specialized diagnostic instruments and associated consumables. The company's transactions are primarily direct sales to biotech and pharmaceutical firms, requiring their products for research and development purposes.Following the acquisition in May 2022, NanoView Diagnostics Inc. plans to leverage Unchained Labs' resources to accelerate the introduction of LentiView to the gene therapy research community. NanoView aims to expand its offerings and meet the increasing demand for advanced biological analysis tools within these regions.
Who invested in NanoView Diagnostics
3 investors across 1 round
See all investors in NanoView Diagnostics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Oct 10, 2018
Amount
$10M
Investors
Questions about NanoView Diagnostics
Who invested in NanoView Diagnostics?
NanoView Diagnostics has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has NanoView Diagnostics raised?
NanoView Diagnostics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did NanoView Diagnostics last raise money?
NanoView Diagnostics's most recent round on record is a Series B, in Oct 2018.
What does NanoView Diagnostics do?
NanoView Diagnostics is a biotechnology company.
Where is NanoView Diagnostics headquartered?
NanoView Diagnostics is headquartered in Boston, US.
Which VCs invest in companies like NanoView Diagnostics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at NanoView Diagnostics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like NanoView Diagnostics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.